Copper Histidine Therapy for Menkes Diseases

计划入组 60 人 · 首次发布于 1999 年 11 月 4 日

Histidine Supplementation for Antitumor Immunity in Colorectal Cancer

计划入组 20 人 · 首次发布于 2026 年 5 月 11 日

Histidine and Immunotherapy Response in Colorectal Cancer

计划入组 150 人 · 首次发布于 2026 年 5 月 14 日

Histidine(Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %)

C₆H₉N₃O₂

Tetrazolyl Histidine

C₇H₉N₇O

Histidine zinc hydrate

Exelixis, Inc.

United States

Inhibikase Therapeutics

United States

Regeneron Pharmaceuticals

United States

Next-Generation Kinase Inhibitors Summit to Address Key Challenges in Cancer Treatment Development

JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases

CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer